Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Applications of Liquid Biopsy Webinar Series – Breast Cancer

ESMO-Webinar-Series-Liquid-Biopsy-in-Breast-Cancer-1000x250

Airs on 6 October 2021 at 18:00 CEST

Start date
06 Oct 2021
End date
06 Oct 2021
Live on
06 Oct 2021

Register now

This webinar aims to review and discuss data for liquid biopsy-based assessments as endpoints of antitumour activity in clinical trials, understand the potential and limitations of liquid biopsy-based tumour genomic profiling for patient stratification and detection of predictive biomarkers of response to therapy, and to discuss how tumour heterogeneity and evolution assessed via liquid biopsy assays may improve breast cancer treatment strategies.

The webinar will also offer the opportunity for real-time interaction between audience and experts.

Chair

Monica Arnedos

Speakers

Michail Ignatiadis, Pedram Razavi, Nicholas Turner

Programme

  • Welcome & Introduction, Dr. Monica Arnedos, Breast Cancer Unit, Institut Bergonié, Bordeaux, France
  • Integrating Liquid Biopsies in Clinical Trials and Clinical Practice for Breast CancerDr. Michail Ignatiadis, Medical Oncology Department, Jules Bordet Institute, Université Libre de Bruxelles, Brussels, Belgium
  • The Use of Liquid Biopsy Profiling for Prognosis, Biomarker Discovery and Patient Stratification in Breast Cancer, Dr. Pedram Razavi, Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, US
  • The Use of Liquid Biopsy Dynamics to Capture Tumour Evolution and Drug Resistance in Early and Advanced Breast Cancer, Prof. Nicholas Turner, Breast Unit, Royal Marsden; Institute of Cancer Unit, London, UK
  • Q&A
  • Closing Remarks, Dr. Monica Arnedos, Breast Cancer Unit, Institut Bergonié, Bordeaux, France

Learning objectives

  • Understand how to integrate liquid biopsy in clinical trials for breast cancer patients in terms of concepts of patient identification to surrogates of standard endpoints
  • Understand the use of liquid biopsy profiling in breast cancer for prognosis, biomarker discovery and patient stratification 
  • Understand the use of liquid biopsy dynamics to capture tumour evolution and drug resistance in breast cancer

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings